Latest Articles
- ArticleInsufficient treatment of severe depression in neuromyelitis optica spectrum disorderVelina S. Chavarro, Maureen A. Mealy, Alexandra Simpson, et al.October 24, 2016
- ArticleNatalizumab treatment leads to an increase in circulating CXCR3-expressing B cellsMaija Saraste, Tarja-Leena Penttilä, Laura AirasOctober 24, 2016
- Clinical/Scientific NotesIntracranial multifocal Rosai-Dorfman diseaseHan Chen, Haiyan Zhou, Zhi SongOctober 24, 2016
- ArticleAlemtuzumab treatment alters circulating innate immune cells in multiple sclerosisCatharina C. Gross, Diana Ahmetspahic, Tobias Ruck, et al.October 12, 2016
- ArticleInduction of gut regulatory CD39+ T cells by teriflunomide protects against EAEJavier Ochoa-Repáraz, Sara L. Colpitts, Christopher Kircher, et al.October 12, 2016
- ArticleCancer association as a risk factor for anti-HMGCR antibody-positive myopathyMasato Kadoya, Ayumi Hida, Meiko Hashimoto Maeda, et al.October 07, 2016
- CorrectionSerotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndromeOctober 07, 2016
- CorrectionComprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosisOctober 07, 2016
- Views & ReviewsImmunology of neuromyelitis optica during pregnancyVahid Davoudi, Kiandokht Keyhanian, Riley M. Bove, et al.October 07, 2016
Pages
Advertisement
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker